© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Submissions, editorial process and impact factor 1992–2000
Focus on Europe
Editorial Office of Cardiovascular Research, Academic Medical Center, Room J-127, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
* Corresponding author. Present address: Department of Medical Physiology, University Medical Center Utrecht, the Netherlands. Tel.: +31-30-253-8923; fax: +31-30-253-9036 t.opthof{at}med.uu.nl
Received 23 May 2000; accepted 23 May 2000
In the August 1999 issue of Cardiovascular Research at the occasion of the congress of the European Society of Cardiology in Barcelona [1] we commented on the increase in submissions and publications from Europe from 1992 to 1998 [2–4]. Now, one year later at the occasion of the 2000 version of the same congress in Amsterdam, we present statistical data on the number of submissions, the editorial process and the impact factor in past and future.
| Submissions |
|---|
|
|
|---|
Fig. 1 shows that the submissions in 1999 came primarily from Europe (56%) and from North-America (22%) with 11% from both Japan and the rest of the world. The estimates for 2000 (by 1 June 2000) are somewhat higher for Japan and lower for North-America. Fig. 2 shows the absolute number of submissions for Europe and North-America. For the first time we received over 600 manuscripts from Europe (611), which is now about the same as the total number of submissions during the years 1992–1995. Fig. 2 also shows that the percentual decrease in submissions from North-America (Fig. 1) results from the increase in submissions from other parts of the world, because the absolute number of submissions from North-America is stable at about 250 per year over the last 8 years. Figs. 3 and 4
|
|
|
|
| Editorial process |
|---|
|
|
|---|
Although the Editorial Team no longer aims at a further reduction of the time needed for a first decision on a manuscript, Fig. 5 shows that this time dropped from 27.6 days in 1996 to 25.8 days in 1999. Our reviewers in the first place, but also our office managers, Nicole Mommertz and Yvonne Zwiers, are responsible for this success, which is even more impressive when the increase in the total number of submissions from 733 in 1996 to 1100 in 1999 is considered. Fig. 6 shows that 50% of the decisions is made within 25 days (dashed line) and that after one month 82% of the manuscripts has been decided on (dotted line). These numbers also show minor improvements over the last years [5].
|
|
| Impact factor |
|---|
|
|
|---|
Fig. 7 shows the official impact factors for Cardiovascular Research as communicated by the Institute for Scientific Information (solid line) and our own estimates over the last years (dotted line). For 1999 we predict an impact factor of 3.44 (see also [6]) and for the year 2000 we anticipate to exceed the 4.00 border for the first time in the history of the journal. The difference between the solid and dotted lines give an impression of the accuracy of these numbers, although it should be emphasized that this accuracy only applies to the prediction for 1999. The prediction for 2000 is based on counts over the period January–May 2000 with extrapolation to the end of the year. Whatever the exact values will be, we continue to invite our authors to send us their very best work, because it is obvious that Cardiovascular Research is successful in bridging the gap with the top in the cardiovascular category of the Science Citation Index.
|
Finally, Fig. 8 shows the impact factors of the individual issues of the journal since April 1996. The abscissa shows the months of publication with numbers for regular issues and abbreviations for spotlight issues. The issues on Mechanoelectrical Feedback (MEL), Microcirculation (MIC) and Calcium and Heart Failure (CAL) were more successful than the averaged impact factor of 3.05 over the years 1996–1998 (dashed line). Also, all issues published since July 1997 had an equal or higher impact factor than the average of the last years. It is obvious that we will maintain our policy with respect to our spotlight issues and we cordially invite you to submit your best work when a new spotlight issue relevant to your specialty is launched.
|
| Notes |
|---|
1 Experimental and Molecular Cardiology Group.
2 On behalf of the Editorial Team. ![]()
| References |
|---|
|
|
|---|
- Opthof T. On behalf of the Editorial Team of Cardiovascular Research. Submissions, publications and reviewers from Europe: focus on Spain. Cardiovasc Res (1999) 43:265–267.
[Free Full Text] - Opthof T. On behalf of the Editorial Team of Cardiovascular Research. Geographical shifts in submissions. Cardiovasc Res (1998) 38:1–2.
[Free Full Text] - Opthof T. On behalf of the Editorial Team of Cardiovascular Research. Increase in submissions from Europe — from where and since when? Cardiovasc Res (1998) 39:261–262.
[Free Full Text] - Opthof T. On behalf of the Editorial Team of Cardiovascular Research. Geographical shifts in publications. Cardiovasc Res (1999) 42:1–2.
[Free Full Text] - Opthof T. On behalf of the Editorial Team of Cardiovascular Research. Submissions, acceptance rate, rapid review system and impact factor. Cardiovasc Res (1999) 41:1–4.
[Free Full Text] - Opthof T., Janse M.J. Reducing the backlog and improving the impact. Cardiovasc Res (1999) 43:1.
[Free Full Text]
This article has been cited by other articles:
![]() |
M. J. Tobin Impact Factor and the Journal Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 621 - 622. [Full Text] [PDF] |
||||
![]() |
T. Opthof, R. Coronel, and M. J Janse Submissions and impact factor 1997-2001: Focus on Sweden Cardiovasc Res, August 1, 2001; 51(2): 202 - 204. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||









